Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Tumor lysis syndrome with massive hyperphosphatemia and hyperuricemia. Clin Case Rep 2017 12;5(12):2158-2159

Date

12/12/2017

Pubmed ID

29225880

Pubmed Central ID

PMC5715431

DOI

10.1002/ccr3.1268

Abstract

Tumor lysis syndrome (TLS) occurs when tumor cells release their contents into the bloodstream, typically in response to chemotherapy, leading to the characteristic findings of hyperuricemia, hyperkalemia, hyperphosphatemia, hypocalcemia, and acute kidney injury. Twinkle artifacts on renal ultrasound may indicate calcium phosphate deposits in such patients.

Author List

Koratala A

Author

Abhilash Koratala MD Associate Professor in the Medicine department at Medical College of Wisconsin